Annual Total Expenses
$103.70 M
-$57.55 M-35.69%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual total expenses is $103.70 million, with the most recent change of -$57.55 million (-35.69%) on December 31, 2023.
- During the last 3 years, RLMD annual total expenses has risen by +$42.86 million (+70.45%).
- RLMD annual total expenses is now -35.69% below its all-time high of $161.25 million, reached on December 31, 2022.
Performance
RLMD Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$23.01 M
+$4.19 M+22.26%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly total expenses is $23.01 million, with the most recent change of +$4.19 million (+22.26%) on September 30, 2024.
- Over the past year, RLMD quarterly total expenses has increased by +$20.90 thousand (+0.09%).
- RLMD quarterly total expenses is now -49.44% below its all-time high of $45.51 million, reached on June 30, 2022.
Performance
RLMD Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RLMD Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.7% | +0.1% |
| 3 y3 years | +70.5% | -46.1% |
| 5 y5 years | +714.8% | +520.6% |
RLMD Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.7% | at low | -49.4% | +22.3% |
| 5 y | 5-year | -35.7% | +1153.7% | -49.4% | +520.6% |
| alltime | all time | -35.7% | >+9999.0% | -49.4% | >+9999.0% |
Relmada Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.01 M(+22.3%) |
| Jun 2024 | - | $18.82 M(-18.1%) |
| Mar 2024 | - | $22.99 M(-14.3%) |
| Dec 2023 | $103.70 M(-35.7%) | $26.83 M(+18.2%) |
| Sep 2023 | - | $22.69 M(-12.8%) |
| Jun 2023 | - | $26.03 M(-7.6%) |
| Mar 2023 | - | $28.15 M(-27.3%) |
| Dec 2022 | $161.25 M(+28.3%) | $38.70 M(-0.1%) |
| Sep 2022 | - | $38.74 M(-14.9%) |
| Jun 2022 | - | $45.51 M(+18.8%) |
| Mar 2022 | - | $38.30 M(+12.0%) |
| Dec 2021 | $125.70 M(+106.6%) | $34.18 M(-19.9%) |
| Sep 2021 | - | $42.65 M(+61.2%) |
| Jun 2021 | - | $26.46 M(+18.1%) |
| Mar 2021 | - | $22.41 M(+7.1%) |
| Dec 2020 | $60.84 M(+635.5%) | $20.92 M(+21.8%) |
| Sep 2020 | - | $17.18 M(+34.7%) |
| Jun 2020 | - | $12.76 M(+27.9%) |
| Mar 2020 | - | $9.97 M(+169.0%) |
| Dec 2019 | $8.27 M(-35.0%) | - |
| Sep 2019 | - | $3.71 M(-10.4%) |
| Jun 2019 | $12.73 M(+84.0%) | $4.14 M(+53.1%) |
| Mar 2019 | - | $2.70 M(-22.3%) |
| Dec 2018 | - | $3.48 M(+44.3%) |
| Sep 2018 | - | $2.41 M(+24.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | $6.92 M(-4.2%) | $1.93 M(-24.3%) |
| Mar 2018 | - | $2.55 M(+75.1%) |
| Dec 2017 | - | $1.46 M(+48.5%) |
| Sep 2017 | - | $980.90 K(-45.0%) |
| Jun 2017 | $7.22 M(-55.5%) | $1.78 M(-21.9%) |
| Mar 2017 | - | $2.28 M(+48.6%) |
| Dec 2016 | - | $1.54 M(-5.0%) |
| Sep 2016 | - | $1.62 M(-47.9%) |
| Jun 2016 | $16.22 M(-5.2%) | $3.10 M(+12.9%) |
| Mar 2016 | - | $2.75 M(-52.0%) |
| Dec 2015 | - | $5.72 M(+23.6%) |
| Sep 2015 | - | $4.63 M(+5.1%) |
| Jun 2015 | $17.10 M(+32.1%) | $4.40 M(-3.8%) |
| Mar 2015 | - | $4.58 M(+4.4%) |
| Dec 2014 | - | $4.38 M(+17.8%) |
| Sep 2014 | - | $3.72 M(>+9900.0%) |
| Jun 2014 | $12.95 M(>+9900.0%) | - |
| Feb 2014 | - | $3800.00(-76.5%) |
| Nov 2013 | - | $16.20 K(+30.6%) |
| Aug 2013 | $50.10 K(+155.6%) | $12.40 K(-38.3%) |
| May 2013 | - | $20.10 K(+209.2%) |
| Feb 2013 | - | $6500.00(-42.0%) |
| Nov 2012 | - | $11.20 K(+10.9%) |
| Aug 2012 | $19.60 K | $10.10 K(+248.3%) |
| May 2012 | - | $2900.00(-53.2%) |
| Feb 2012 | - | $6200.00 |
FAQ
- What is Relmada Therapeutics annual total expenses?
- What is the all time high annual total expenses for Relmada Therapeutics?
- What is Relmada Therapeutics annual total expenses year-on-year change?
- What is Relmada Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly total expenses year-on-year change?
What is Relmada Therapeutics annual total expenses?
The current annual total expenses of RLMD is $103.70 M
What is the all time high annual total expenses for Relmada Therapeutics?
Relmada Therapeutics all-time high annual total expenses is $161.25 M
What is Relmada Therapeutics annual total expenses year-on-year change?
Over the past year, RLMD annual total expenses has changed by -$57.55 M (-35.69%)
What is Relmada Therapeutics quarterly total expenses?
The current quarterly total expenses of RLMD is $23.01 M
What is the all time high quarterly total expenses for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly total expenses is $45.51 M
What is Relmada Therapeutics quarterly total expenses year-on-year change?
Over the past year, RLMD quarterly total expenses has changed by +$20.90 K (+0.09%)